J. Safra Sarasin Holding Ag Xenon Pharmaceuticals Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.91 Trillion
- Q4 2024
A detailed history of J. Safra Sarasin Holding Ag transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 17,786 shares of XENE stock, worth $609,348. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,786Holding current value
$609,348% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding XENE
# of Institutions
218Shares Held
66.7MCall Options Held
109KPut Options Held
2.1K-
Avoro Capital Advisors LLC New York, NY5.67MShares$194 Million3.24% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.52MShares$155 Million1.73% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$99.8 Million6.4% of portfolio
-
Janus Henderson Group PLC London, X02.87MShares$98.2 Million0.06% of portfolio
-
Commodore Capital LP New York, NY2.74MShares$93.9 Million10.76% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.13B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...